0001209191-21-020929.txt : 20210316
0001209191-21-020929.hdr.sgml : 20210316
20210316171243
ACCESSION NUMBER: 0001209191-21-020929
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210312
FILED AS OF DATE: 20210316
DATE AS OF CHANGE: 20210316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ledda Ralf
CENTRAL INDEX KEY: 0001690024
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15103
FILM NUMBER: 21746920
MAIL ADDRESS:
STREET 1: ONE INVACARE WAY
CITY: ELYRIA
STATE: OH
ZIP: 44035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INVACARE CORP
CENTRAL INDEX KEY: 0000742112
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 952680965
STATE OF INCORPORATION: OH
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
BUSINESS PHONE: 4403296000
MAIL ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-12
0
0000742112
INVACARE CORP
IVC
0001690024
Ledda Ralf
ONE INVACARE WAY
ELYRIA
OH
44035
0
1
0
0
Sen VP/GM-EUR,Mid East&Africa
Common Shares
2021-03-21
4
A
0
9270
0.00
A
91411
D
Employee Stock Option (Right to Buy)
Common Shares
51433
51433
D
Restricted stock units granted pursuant to the Invacare Corporation 2018 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These restricted stock units vest in 1/3 annual increments over three years commencing on May 15, 2022.
Includes 21,064 previously reported restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan. 1,680 of these restricted stock units vest on May 15, 2021; 8,872 of these restricted stock units vest in 1/2 increments on May 15, 2021 and May 15, 2022; and 10,512 of these restricted stock units vest in 1/3 annual increments over three years commencing on May 15, 2021.
No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4 or Form 5.
The reporting person holds previously reported options to buy 51,433 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan and the Invacare Corporation 2013 Equity Compensation Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between September 2, 2011 and March 16, 2017, at exercise prices between $12.15 to $24.45 per share, will expire between September 2, 2021 and March 16, 2027, and became exercisable between September 30, 2012 and February 19, 2020.
The current balance reflects the expiration of 2,300 options on August 18, 2020.
/s/ Ralf Ledda, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated November 10, 2016, on file with the Commission
2021-03-16